These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Formulation and in-vitro evaluation of floating microballoons of indomethacin. Bhardwaj P; Chaurasia H; Chaurasia D; Prajapati SK; Singh S Acta Pol Pharm; 2010; 67(3):291-8. PubMed ID: 20524432 [TBL] [Abstract][Full Text] [Related]
3. Raman and thermal analysis of indomethacin/PVP solid dispersion enteric microparticles. Fini A; Cavallari C; Ospitali F Eur J Pharm Biopharm; 2008 Sep; 70(1):409-20. PubMed ID: 18621516 [TBL] [Abstract][Full Text] [Related]
4. Solid lipid nanoparticles loaded with insulin by sodium cholate-phosphatidylcholine-based mixed micelles: preparation and characterization. Liu J; Gong T; Wang C; Zhong Z; Zhang Z Int J Pharm; 2007 Aug; 340(1-2):153-62. PubMed ID: 17428627 [TBL] [Abstract][Full Text] [Related]
5. Combining SEM, TEM, and micro-Raman techniques to differentiate between the amorphous molecular level dispersions and nanodispersions of a poorly water-soluble drug within a polymer matrix. Karavas E; Georgarakis M; Docoslis A; Bikiaris D Int J Pharm; 2007 Aug; 340(1-2):76-83. PubMed ID: 17478064 [TBL] [Abstract][Full Text] [Related]
6. Sugar coated ceramic nanocarriers for the oral delivery of hydrophobic drugs: formulation, optimization and evaluation. Kommineni S; Ahmad S; Vengala P; Subramanyam CV Drug Dev Ind Pharm; 2012 May; 38(5):577-86. PubMed ID: 21961937 [TBL] [Abstract][Full Text] [Related]
7. Enhancement of the dissolution of indomethacin in interactive mixtures using added fine lactose. Allahham A; Stewart PJ Eur J Pharm Biopharm; 2007 Nov; 67(3):732-42. PubMed ID: 17540551 [TBL] [Abstract][Full Text] [Related]
8. Incorporation of indomethacin nanoparticles into 3-D ordered macroporous silica for enhanced dissolution and reduced gastric irritancy. Hu Y; Zhi Z; Wang T; Jiang T; Wang S Eur J Pharm Biopharm; 2011 Nov; 79(3):544-51. PubMed ID: 21767643 [TBL] [Abstract][Full Text] [Related]
9. Preparation and characterization of aspirin/chitosan nanoparticles by nucleation and ionic crosslinking in micro emulsions. Jin S; Feng L; Yu X J Control Release; 2011 Nov; 152 Suppl 1():e39-41. PubMed ID: 22195912 [No Abstract] [Full Text] [Related]
10. Controlled poorly soluble drug release from solid self-microemulsifying formulations with high viscosity hydroxypropylmethylcellulose. Yi T; Wan J; Xu H; Yang X Eur J Pharm Sci; 2008 Aug; 34(4-5):274-80. PubMed ID: 18541418 [TBL] [Abstract][Full Text] [Related]
11. Effect of melt sonocrystallization on pharmacotechnical properties of paracetamol, indomethacin and mefenamic acid characterized by dynamic laser scattering and its impact on solubility. Kumar B; Sharma V; Pathak K Drug Dev Ind Pharm; 2013 May; 39(5):687-95. PubMed ID: 22630048 [TBL] [Abstract][Full Text] [Related]
12. Synthesis of novel mesoporous silica nanoparticles for loading and release of ibuprofen. Zhang H; Li Z; Xu P; Wu R; Wang L; Xiang Y; Jiao Z J Control Release; 2011 Nov; 152 Suppl 1():e38-9. PubMed ID: 22195911 [No Abstract] [Full Text] [Related]
13. Formation of bicalutamide nanodispersion for dissolution rate enhancement. Li C; Li C; Le Y; Chen JF Int J Pharm; 2011 Feb; 404(1-2):257-63. PubMed ID: 21093558 [TBL] [Abstract][Full Text] [Related]
14. Counter-intuitive enhancement in the dissolution of indomethacin with the incorporation of cohesive poorly water-soluble inorganic salt additives. Tay T; Allahham A; Morton DA; Stewart PJ Eur J Pharm Biopharm; 2011 Nov; 79(3):674-82. PubMed ID: 21703348 [TBL] [Abstract][Full Text] [Related]
15. New solid lipid microparticles for controlled ibuprofen release: formulation and characterization study. Perge L; Robitzer M; Guillemot C; Devoisselle JM; Quignard F; Legrand P Int J Pharm; 2012 Jan; 422(1-2):59-67. PubMed ID: 22027394 [TBL] [Abstract][Full Text] [Related]
16. Adhesion and redistribution of salmeterol xinafoate particles in sugar-based mixtures for inhalation. Adi H; Larson I; Stewart PJ Int J Pharm; 2007 Jun; 337(1-2):229-38. PubMed ID: 17303354 [TBL] [Abstract][Full Text] [Related]
17. Functionalized (poly(ɛ-caprolactone))₂-poly(ethylene glycol) nanoparticles with grafting nicotinic acid as drug carriers. Suksiriworapong J; Sripha K; Kreuter J; Junyaprasert VB Int J Pharm; 2012 Feb; 423(2):562-70. PubMed ID: 22155410 [TBL] [Abstract][Full Text] [Related]
18. Effervescent dry powder for respiratory drug delivery. Ely L; Roa W; Finlay WH; Löbenberg R Eur J Pharm Biopharm; 2007 Mar; 65(3):346-53. PubMed ID: 17156987 [TBL] [Abstract][Full Text] [Related]
19. Diffusion and mathematical modeling of release profiles from nanocarriers. Cruz L; Soares LU; Costa TD; Mezzalira G; da Silveira NP; Guterres SS; Pohlmann AR Int J Pharm; 2006 Apr; 313(1-2):198-205. PubMed ID: 16503103 [TBL] [Abstract][Full Text] [Related]